Suppr超能文献

补体受体3和清道夫受体AI/II介导小胶质细胞和巨噬细胞中的髓鞘吞噬作用。

Complement-receptor-3 and scavenger-receptor-AI/II mediated myelin phagocytosis in microglia and macrophages.

作者信息

Reichert Fanny, Rotshenker Shlomo

机构信息

Department of Anatomy & Cell Biology, Hebrew University-Hadassah Medical School and the Eric Roland Center for Neurodegenerative Diseases, Jerusalem 91120, Israel.

出版信息

Neurobiol Dis. 2003 Feb;12(1):65-72. doi: 10.1016/s0969-9961(02)00008-6.

Abstract

Microglia and macrophages express the alpha(M)/beta(2) integrin complement-receptor-3 (CR3/MAC-1; CD11b/CD18) and scavenger-receptor-AI/II (SRAI/II). Both can mediate myelin phagocytosis. We document that CR3/MAC-1 mediated myelin phagocytosis in microglia is modulated by complement and anti-CR3/MAC-1 mAbs. Complement augmented phagocytosis twofold. Anti-alpha(M) mAbs M1/70 and 5C6 inhibited and anti-beta(2) mAb M18/2 augmented myelin phagocytosis in the presence and absence of active complement. Active complement modulated phagocytosis inhibition by M1/70 and 5C6 and phagocytosis augmentation by M18/2. CR3/MAC-1 mediated myelin phagocytosis may thus be, at least partially, independent of but modulated by complement. Anti-beta(2) mAb Game-46 did not affect phagocytosis. However, combining M18/2 with Game-46 resulted in phagocytosis augmentation that was larger in magnitude than that induced by M18/2 alone. Thus, phagocytosis augmentation induced by one anti-beta(2) mAb was potentiated by another anti-beta(2) mAb. Combining M1/70 or 5C6 with M18/2 inhibited M18/2-induced augmentation. Overall, mAbs-induced phagocytosis modulation ranged three- to sevenfold from inhibition to augmentation. Anti-CR3/MAC-1 mAbs may reveal a mechanism by which native extracellular molecules bind to and modulate CR3/MAC-1 mediated myelin phagocytosis in microglia and macrophages. We further document SRAI/II mediated myelin phagocytosis in microglia and CR3/MAC-1 contributing to myelin phagocytosis two- to threefold more than SRAI/II when the two receptors function together.

摘要

小胶质细胞和巨噬细胞表达α(M)/β(2)整合素补体受体-3(CR3/MAC-1;CD11b/CD18)和清道夫受体-AI/II(SRAI/II)。二者均可介导髓磷脂吞噬作用。我们证明,小胶质细胞中CR3/MAC-1介导的髓磷脂吞噬作用受补体和抗CR3/MAC-1单克隆抗体的调节。补体使吞噬作用增强了两倍。在有或没有活性补体存在的情况下,抗α(M)单克隆抗体M1/70和5C6抑制髓磷脂吞噬作用,而抗β(2)单克隆抗体M18/2增强髓磷脂吞噬作用。活性补体调节M1/70和5C6对吞噬作用的抑制以及M18/2对吞噬作用的增强。因此,CR3/MAC-1介导的髓磷脂吞噬作用可能至少部分独立于补体,但受补体调节。抗β(2)单克隆抗体Game-46不影响吞噬作用。然而,将M18/2与Game-46联合使用导致吞噬作用增强,其幅度大于单独使用M18/2所诱导的增强幅度。因此,一种抗β(2)单克隆抗体诱导的吞噬作用增强被另一种抗β(2)单克隆抗体增强。将M1/70或5C6与M18/2联合使用可抑制M18/2诱导的增强作用。总体而言,单克隆抗体诱导的吞噬作用调节范围从抑制到增强为三到七倍。抗CR3/MAC-1单克隆抗体可能揭示了一种天然细胞外分子结合并调节小胶质细胞和巨噬细胞中CR3/MAC-1介导的髓磷脂吞噬作用的机制。我们进一步证明,小胶质细胞中SRAI/II介导髓磷脂吞噬作用,并且当这两种受体共同发挥作用时,CR3/MAC-1对髓磷脂吞噬作用的贡献比SRAI/II多两到三倍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验